PEPFAR and the global medical technology company BD announced an iniative Tuesday that will work to improve blood collection safety in clinics and hospitals in sub-Saharan Africa â€“ an issue that PANA/Afrique en ligne reports has “become more critical than ever in sub-Saharan nations and other developing countries severely impacted by the HIV/AIDS pandemic.”
TIME examines the international fight against H1N1 (swine) flu, including current efforts to produce an H1N1 vaccine and prepare the northern hemisphere for the expected surge in infections this fall.
Beginning on Thursday, “Mumbai, Indiaâ€™s commercial capital, will shut schools and movie theaters as swine flu-related deaths jumped, ignoring federal government advice to keep educational institutions open,” Bloomberg reports.
The AP/San Francisco Chronicle examines Los Alamos National Laboratory researchers’ efforts to create an automated network to monitor animals in an effort to predict disease outbreaks because two out of every three human diseases “originated in animals.”
The Agence-France Press examines the debate over how much developed countries are spending to fight the H1N1 virus.
Inter Press Service examines how efforts underway in Namibia have helped to decrease the number of infants born with HIV while also increasing the number of HIV-positive infants on life-saving antiretrovirals (ARVs).
The U.S., WHO and representatives from 13 African countries on Monday launched an effort to boost the standards for quality medical labs on the continent, VOA News reports.
The WHO on Friday said the “H1N1 swine-flu virus could infect up to two billion people over the next two years – about one of every three people in the world,” VOA News reports.
IAS Conference: Low-Cost CD4 Tests; HIV Prevalence Among Pregnant Zimbabweans; Treating HIV-TB With ARVs; Vaccine Trials
The following are stories fromÂ this week’sÂ 5th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention meeting in Cape Town, South Africa: SciDev.Net: Steven ReidÂ of theÂ Imperial College London spoke of three prototype tests he and his colleagues have been working on that would help to increase access to CD4…
“Global health officials are scrambling to try to prevent the spread of the H1N1 swine flu virus, with U.S. officials moving Thursday with a recommendation that the Food and Drug Administration approve or license a [new H1N1] vaccine,” without waiting on the results from “clinical trials to test its safety and efficacy,” Wall Street Journal reports (Dooren/Winning, 7/24).